Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bright Minds Biosciences | CSE | Healthcare | Biotechnology & Medical Research | $306.12M | -89x | -1.72 | $43.80 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | $284.11M | -1.6x | -0.16 | $14.33 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fennec Pharma | Toronto | Healthcare | Biotechnology & Medical Research | $255.47M | -154.2x | -1.6 | $9.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | $198.27M | -6.8x | 0.74 | $2.87 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ME Therapeutics Holdings | CSE | Healthcare | Biotechnology & Medical Research | $176.33M | $7 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | $165.46M | -15x | -1.24 | $1.59 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $164.02M | -3.8x | 0.21 | $2 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | $151.40M | -3.5x | -0.17 | $4.30 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | $101.01M | -3.5x | 0.03 | $1.28 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | $91.05M | -3.2x | 0.17 | $0.80 | -5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.6% Upside | Upgrade to Pro+ | |
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | $83.24M | -2.9x | -0.11 | $1.08 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | $72.81M | -372.5x | -3.29 | $1.37 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | $63.73M | 18.1x | 0 | $0.47 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | $62.46M | -1.6x | 0.46 | $0.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sharp Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $62.09M | -0x | $2.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $55.43M | 0.08 | $1.15 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $55.43M | 0.08 | $1.15 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Hemostemix Inc | TSXV | Healthcare | Biotechnology & Medical Research | $48.52M | -15.7x | -0.61 | $0.34 | 9.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | $47.37M | -5.8x | 0.05 | $0.26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $45.10M | -4.5x | 0.13 | $0.92 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | $38.99M | -7.2x | -0.34 | $0.54 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $30.95M | -7x | 4.34 | $0.74 | 8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sona Nanotech | CSE | Healthcare | Biotechnology & Medical Research | $30.16M | -8.7x | 0.05 | $0.27 | -6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | $29.21M | -4.6x | -0.09 | $0.28 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rakovina Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $27.36M | -2.2x | 0.44 | $0.19 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $23.87M | -0.4x | -0.02 | $8.10 | -8.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmala Biotech Holdings | CSE | Healthcare | Biotechnology & Medical Research | $22.76M | $0.22 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | $17.54M | -10.2x | 0.3 | $0.22 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovaxys Technology | CSE | Healthcare | Biotechnology & Medical Research | $17.12M | -0.06 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $16.84M | -0.6x | 0.09 | $0.13 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $16.84M | -0.6x | 0.09 | $0.13 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Numinus Wellness Inc | Toronto | Healthcare | Biotechnology & Medical Research | $16.12M | -0.5x | -0.01 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Resverlogix Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $15.50M | -0.9x | -0.06 | $0.05 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSCIENS Biopharma | Toronto | Healthcare | Biotechnology & Medical Research | $15.07M | -0.2x | 0.02 | $4.01 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sirona Biochem Corp | TSXV | Healthcare | Biotechnology & Medical Research | $14.50M | -5.5x | 0.39 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | $11.86M | -0.18 | $0.07 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | $11.86M | -0.18 | $0.07 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Telo Genomics | TSXV | Healthcare | Biotechnology & Medical Research | $10.81M | -4x | -0.25 | $0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innovotech | TSXV | Healthcare | Biotechnology & Medical Research | $9.45M | -27.1x | 1.72 | $0.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicure | TSXV | Healthcare | Biotechnology & Medical Research | $8.56M | -4.2x | 0.01 | $0.82 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum BioPharma | CSE | Healthcare | Biotechnology & Medical Research | $8.06M | -0.2x | -0.01 | $4.20 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marvel Biosciences | TSXV | Healthcare | Biotechnology & Medical Research | $6.94M | -5x | -0.1 | $0.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Principal Tech | TSXV | Healthcare | Biotechnology & Medical Research | $6.20M | -2.8x | 0.28 | $0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quest PharmaTech | TSXV | Healthcare | Biotechnology & Medical Research | $5.92M | -2.9x | -0.03 | $0.04 | 40% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CSE | Healthcare | Biotechnology & Medical Research | $5.76M | -1.1x | -0.02 | $0.08 | 66.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CBOE Canada | Healthcare | Biotechnology & Medical Research | $5.76M | -1.1x | -0.02 | $0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MYND Life Sciences | CSE | Healthcare | Biotechnology & Medical Research | $5.02M | -3.4x | -0.12 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
StageZero Life Sciences | Toronto | Healthcare | Biotechnology & Medical Research | $4.94M | -0.2x | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
XORTX Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $4.60M | -3.2x | -0.05 | $1.32 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Appili Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $4.24M | -1x | -0.02 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |